89bio, Inc. (ETNB)
NASDAQ: ETNB · IEX Real-Time Price · USD
11.64
+0.33 (2.92%)
At close: Mar 28, 2024, 4:00 PM
11.70
+0.06 (0.52%)
After-hours: Mar 28, 2024, 6:36 PM EDT

89bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-142.19-102.03-90.12-49.5-57.42-16.18
Depreciation & Amortization
0.270.240.080.060.020.01
Share-Based Compensation
16.1110.368.683.810.390.11
Other Operating Activities
-3.3810.344.58-0.6131.553.59
Operating Cash Flow
-129.19-81.09-76.78-46.24-25.46-12.47
Capital Expenditures
-0-0.01-0.06-0.13-0.14-0.04
Change in Investments
-123.02-33.947.22-106.7100
Investing Cash Flow
-123.02-33.947.16-106.83-0.14-0.04
Share Issuance / Repurchase
512.42118.133.92157.8187.70
Debt Issued / Paid
2.96019.95-0.1600.1
Other Financing Activities
-2.28-0.3-0.272023.67
Financing Cash Flow
513.11117.8323.87157.92107.723.77
Net Cash Flow
260.912.8-45.754.8582.111.26
Free Cash Flow
-129.19-81.1-76.84-46.37-25.6-12.51
Free Cash Flow Per Share
-1.81-2.33-3.82-2.88-10.92-28.19
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).